Morgan Stanley raised the firm’s price target on Houlihan Lokey (HLI) to $192 from $159 and keeps an Overweight rating on the shares. The firm, which raised its Midcap Advisors Industry View to In-Line due to improving market conditions for dealmaking, expects the pipeline to start moving again, driven by rapidly improving market conditions, regulatory clarity, significant pent-up demand, and structural drivers of M&A, the analyst tells investors in a group note.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
- Houlihan Lokey announces Rogowski joined as Managing Director
- Houlihan Lokey price target raised to $185 from $183 at Keefe Bruyette
- Houlihan Lokey’s Record Revenue Highlights Earnings Call
- Houlihan Lokey price target raised to $185 from $170 at Wells Fargo
- Houlihan Lokey: Strong Financial Performance and Strategic Growth Drive Buy Rating